Literature DB >> 33845794

Decreased blood CD4+ T lymphocyte helps predict cognitive impairment in patients with amyotrophic lateral sclerosis.

Yuan Yang1, Dengji Pan1, Zhenxiang Gong1, Jiahui Tang1, Zehui Li1, Fengfei Ding2, Mao Liu3, Min Zhang4.   

Abstract

BACKGROUND: ALS patients have changed peripheral immunity. It is unknown whether peripheral immunity is related to cognitive dysfunction in ALS patients.
OBJECTIVE: To explore the relationship between the peripheral blood lymphocyte subsets and the cognitive status in ALS patients.
METHODS: Among 81 ALS patients, we compared the demographic, clinical, and peripheral levels of total T lymphocyte, CD4+ T lymphocyte, CD8+ T lymphocyte, B lymphocyte, and NK cell between those with cognitive impairment (ALS-ci) and those without (ALS-nci). The cognitive status was evaluated via the Chinese version of the Edinburgh cognitive and behavioral screen (ECAS). Significant predictors of cognitive impairment in univariate logistic regression analysis were further examined using multivariate logistic regression analysis.
RESULTS: 39.5% of all ALS patients had cognitive impairment. The ALS-ci group had shorter education time, older age at both symptom onset and testing, longer disease duration, and lower levels of peripheral total, CD4+, and CD8+ T lymphocyte and B lymphocyte than the ALS-nci group. Frequency of behavioral impairment did not differ between the two groups. While parameters with significant differences identified by group comparison were also significant predictors of cognitive impairment in univariate logistic regression analysis except the level of B lymphocyte, only older age at testing, education time less than 9 years, and lower level of CD4+ T lymphocyte remained significant in multivariate logistic regression analysis. The predictive model combining these three parameters had an area under the receiver operating characteristic curve value of 0.842 with a sensitivity of 90.6% and a specificity of 67.3%.
CONCLUSION: In Chinese ALS patients, blood CD4+ T lymphocyte might help evaluate cognitive impairment along with age and education level.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Cognitive impairment; ECAS; Peripheral blood lymphocyte subsets

Year:  2021        PMID: 33845794     DOI: 10.1186/s12883-021-02185-w

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  30 in total

1.  Detecting neurobehavioral changes in amyotrophic lateral sclerosis.

Authors:  Alison B Grossman; Susan Woolley-Levine; Walter G Bradley; Robert G Miller
Journal:  Amyotroph Lateral Scler       Date:  2007-02

Review 2.  Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.

Authors:  Paul H Gordon
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

Review 3.  The emerging picture of ALS: a multisystem, not only a "motor neuron disease.

Authors:  Vincenzo Silani; Albert Ludolph; Francesco Fornai
Journal:  Arch Ital Biol       Date:  2017-12-01       Impact factor: 1.000

Review 4.  Decisional Capacity in Amyotrophic Lateral Sclerosis.

Authors:  Eindra Khin Khin; Darlinda Minor; Amanda Holloway; Ayla Pelleg
Journal:  J Am Acad Psychiatry Law       Date:  2015-06

Review 5.  Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis.

Authors:  Jennifer Murphy; Roland Henry; Catherine Lomen-Hoerth
Journal:  Arch Neurol       Date:  2007-03

Review 6.  Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.

Authors:  Michael J Strong; Sharon Abrahams; Laura H Goldstein; Susan Woolley; Paula Mclaughlin; Julie Snowden; Eneida Mioshi; Angie Roberts-South; Michael Benatar; Tibor HortobáGyi; Jeffrey Rosenfeld; Vincenzo Silani; Paul G Ince; Martin R Turner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-01-05       Impact factor: 4.092

Review 7.  Cognitive impairment in amyotrophic lateral sclerosis.

Authors:  Julie Phukan; Niall P Pender; Orla Hardiman
Journal:  Lancet Neurol       Date:  2007-11       Impact factor: 44.182

8.  Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression.

Authors:  Benjamin J Murdock; Tingting Zhou; Samy R Kashlan; Roderick J Little; Stephen A Goutman; Eva L Feldman
Journal:  JAMA Neurol       Date:  2017-12-01       Impact factor: 18.302

Review 9.  Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment.

Authors:  Laura H Goldstein; Sharon Abrahams
Journal:  Lancet Neurol       Date:  2013-03-18       Impact factor: 44.182

10.  Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis.

Authors:  Michael P Gustafson; Nathan P Staff; Svetlana Bornschlegl; Greg W Butler; Mary L Maas; Mohamed Kazamel; Adeel Zubair; Dennis A Gastineau; Anthony J Windebank; Allan B Dietz
Journal:  PLoS One       Date:  2017-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.